Efficacy of operant- and cognitive-behavioral treatments in fibromyalgia syndrome: analysis of psychophysiological reactivity (Th 899/2-1) and analysis of psychophysiological reactivity in fibromyalgia-syndrome after operant- or cognitive-behavioral pain therapy in fibromyalgia-syndrome (Th 899/2-2)

ISRCTN ISRCTN83953414
DOI https://doi.org/10.1186/ISRCTN83953414
Secondary identifying numbers Th 899/2-1, Th 899/2-2
Submission date
17/02/2006
Registration date
20/02/2006
Last edited
28/10/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Dr Kati Thieme
Scientific

1959 NE Pacific Street
Box 356540
Seattle
Washington
98195-6540
United States of America

Phone +1 206 685 2082
Email thiemek@u.washington.edu

Study information

Study designRandomized, placebo-controlled clinical trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeTreatment
Scientific title
Study acronymCBTOBTFMS
Study hypothesis1. Cognitive-Behavioral Therapy (CBT) and Operant-Behavioral Therapy (OBT) will produce significant improvements in pain, physical functioning, and emotional distress in Fibromyalgia Syndrome (FMS) patients
2. CBT and OBT will produce significantly greater improvements in pain, physical functioning, and emotional distress than the Attention Placebo (AP) treatment
3. CBT will produce significantly greater effects than the OBT and AP groups on coping and catastrophizing responses. Since the OBT indirectly focuses on inappropriate beliefs, it will produce significantly greater improvements on coping and catastrophizing than the AP group.
4. OBT will produce significantly greater reductions in pain, behaviors, physical therapy, and medication than CBT or AP treatments. Since CBT indirectly focuses on maladaptive behaviors, it will produce significantly greater improvements in pain behaviors than the AP group.
Ethics approval(s)Approved by Charite, Humboldt-University, Berlin, Germany on 01/02/2000, reference number 1270/2000
ConditionFibromyalgia syndrome
InterventionThe operant- and cognitive-behavioral pain therapy were compared to an attention placebo group (a social discussion group), a physiotherapy and a wait-list control group
Intervention typeOther
Primary outcome measure1. Pain
2. Physical impairment
3. Affective distress
Secondary outcome measures1. Coping
2. Catastrophizing
3. Pain behaviour
4. Number of physician visits
5. Spouse behavior
Overall study start date01/04/2000
Overall study end date01/04/2005

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants180
Participant inclusion criteria1. Participants must suffer from FMS as validated by a rheumatologist
2. They must meet the American College of Rheumatology (ACR) criteria for FMS
3. Pain for a period of at least six months
4. Married, and must show willingness of the spouse to be involved
5. Ability to complete the questionnaires and understand the treatment components
Participant exclusion criteria1. Inflammatory rheumatic diseases
2. Acute episode of carcinoma
3. Psychotic episode
4. Opioid abuse
Recruitment start date01/04/2000
Recruitment end date01/04/2005

Locations

Countries of recruitment

  • Germany
  • United States of America

Study participating centre

1959 NE Pacific Street
Washington
98195-6540
United States of America

Sponsor information

German Research Council (Deutsche Forschungsgemeinschaft) (DFG)
Research organisation

DFG
Kennedyallee 40
Bonn
53170
Germany

Phone +49 (0)22 8885 2626
Email Anne.Brueggemann@dfg.de
Website http://www.dfg.de
ROR logo "ROR" https://ror.org/018mejw64

Funders

Funder type

Charity

German Research Council (Deutsche Forschungsgemeinschaft) (DFG)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/12/2006 Yes No